We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About TenNor Therapeutics Stock

Invest in or calculate the value of your shares in TenNor Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

TenNor Therapeutics Stock (TENT)

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

About TenNor Therapeutics Stock

Founded

2013

Headquarters

Westfield, NJ, US

Industries

Software, Artificial Intelligence, Data and Analytics

TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.

TenNor Therapeutics Management

Leadership team at TenNor Therapeutics

CEO & Founder

Zhenkun Ma

VP Clinical Operations

Xiaomei Wang

Locked Features

Join now and verify your accreditation status to gain access to:

  • TenNor Therapeutics current valuation
  • TenNor Therapeutics stock price
  • Available deals in TenNor Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in TenNor Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like TenNor Therapeutics through EquityZen funds. These investments are made available by existing TenNor Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell TenNor Therapeutics stock?

Shareholders can sell their TenNor Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."